30 September 2021
\n \n \n \nAMR could render many of the current mainstay and last-resort antibiotics useless, resulting in many more deaths from previously treatable infections. In 2019, a UN report estimated that drug-resistant microbes could lead to ten million deaths per year, and cost the world $100trn, by 2050.
\n \n\n \n \n23 September 2021
\n \n \n \nOxford University has been selected as the home of the new Podium Analytics Institute for Youth Sports Medicine and Technology. This will be the world\u2019s first academic Institute focused on young athletes\u2019 safety and lifelong health.
\n \n\n \n \n2 September 2021
\n \n \n \nFor the first time in more than two decades, a team from the KEMRI-Wellcome Trust Research Programme and University of Oxford (including Department of Zoology researchers) have quantified the risk of children suffering severe outcomes from malaria.
\n \n\n \n \n1 September 2021
\n \n \n \nAn Artificial Intelligence (AI) test performed by the bedside in 10 minutes quickly and safely triages patients coming to hospital for COVID-19, a University of Oxford-led study has shown.
\n \n\n \n \n10 August 2021
\n \n \n \nInformation about the most effective antibiotics to use in low and middle income countries (LMICs) for neonatal sepsis has been discovered uniquely combining epidemiological, genomic and pharmacodynamic data.
\n \n\n \n \n8 July 2021
\n \n \n \nThe Oxford-Suzhou Centre for Advanced Research, known as OSCAR, has marked another significant milestone with the launch of OSCAR-Prenetics Innovation and Technology Centre for Advanced Molecular Diagnostics (the OSCAR-Prenetics ITC).
\n \n\n \n \n9 June 2021
\n \n \n \nA cross-disciplinary team from the Universities of Oxford, Ulster and UCL have announced major funding from EPSRC to tackle the growing challenge of Antimicrobial Resistance (AMR).
\n \n\n \n \n3 June 2021
\n \n \n \nA new international study involving University of Oxford researchers has conclusively demonstrated that national lockdowns and public health campaigns introduced at the start of the pandemic have reduced the transmission of bacteria that cause respiratory infections.
\n \n\n \n \n7 May 2021
\n \n \n \nSix scientists from the University of Oxford, including four from MPLS, have joined the Royal Society as Fellows.
\n \n\n \n \n29 April 2021
\n \n \n \nAntibiotic resistance poses a serious threat to human health, but how resistance emerges during infections remains poorly understood.
\n \n\n \n \n29 March 2021
\n \n \n \nTwo engineering DPhil students from the University of Oxford have created a website for GP surgeries across the UK to optimise the delivery of Covid-19 vaccinations to the UK\u2019s 1 million housebound patients.
\n \n\n \n \n10 February 2021
\n \n \n \nResearchers in Oxford have developed a machine learning algorithm that could significantly improve clinicians\u2019 ability to identify hospitalised patients whose condition is deteriorating to the extent that they need intensive care.
\n \n\n \n \n19 January 2021
\n \n \n \nIneos, one of the world\u2019s largest manufacturing companies, and the University of Oxford are launching a new world-leading institute to combat the growing global issue of antimicrobial resistance (AMR), which currently causes an estimated 1.5 million excess deaths each year.
\n \n\n \n \n7 December 2020
\n \n \n \nA new institute for nanoscience research is to open in Oxford thanks to a $10 million gift from The Kavli Foundation.
\n \n\n \n \n21 October 2020
\n \n \n \nProfessor Chris Holmes, The Alan Turing Institute\u2019s Programme Director of Health and Medical Science, and Professor of Biostatistics at Oxford University, will co-lead a new Statistical Modelling and Machine Learning Lab.
\n \n\n \n \n16 October 2020
\n \n \n \nThe Harrington Discovery Institute (HDI) in the US has announced five winners of its inaugural UK Rare Disease Scholar Award competition.
\n \n\n \n \n28 September 2020
\n \n \n \nScientists from the Nuffield Department of Medicine have evaluated LamPORE, a novel diagnostic platform for detecting SARS-CoV-2 RNA. LamPORE was developed by Oxford Nanopore Technologies, a spin-out company from the Department of Chemistry, and has the potential to analyse thousands of samples per day on a single instrument.
\n \n\n \n \n28 July 2020
\n \n \n \nInfectious disease and clinical machine learning experts at the University of Oxford have developed an Artificial Intelligence test that can rapidly screen for COVID-19 in patients arriving in emergency departments.
\n \n\n \n \n11 June 2020
\n \n \n \nOxford University has received a landmark \u00a380 million donation from the Reuben Foundation that will transform Oxford\u2019s newest college and establish a major new scholarship programme for graduate and undergraduate students.
\n \n\n \n \n23 April 2020
\n \n \n \nResearch carried out at Oxford, in collaboration with Columbia University and Barts Cancer Institute at Queen Mary University of London, has revealed that the signature of metal ions present in urine samples is an accurate indicator of pancreatic ductal adenocarcinoma (PDAC), one of the deadliest types of cancer.
\n \n\n \n \n